Key Takeaways
- Guidance raised on strong H1: FY26 revenue guidance revised upward to ₹1,150 crores plus from ₹1,050 crores, after H1 revenue grew 86.4% YoY driven by value-added product mix and international demand.
- Margins healthy, capacity expanding: EBITDA margin stood at 27.2% with PAT margin at 17.2%; a planned Q3 plant shutdown will lift fractionation capacity from 40,000 to 52,000 metric tons annually, with no impact on annual revenue guidance.
- Backward integration advancing: Subsidiaries established in West Africa and an MoU signed with Burkina Faso for a processing facility, aiming to reduce raw material costs and improve working capital.
- CBE pricing decoupled from cocoa butter: CBE prices have held steady at \$5,500–\$6,000 even as cocoa butter swung between \$25,000–\$30,000; management sees demand and pricing as sustainable due to contract structures and CBE's functional properties.
- What to watch next quarter: Execution of the Q3 plant shutdown and capacity expansion timeline, progress on the ~₹450 crore CAPEX funding structure, and any FY27 guidance signals in the March quarter.
Revenue Performance & Drivers
- H1 surge: Revenue grew 86.4% YoY in H1 FY26, attributed to a superior mix of value-added products, optimized utilization of expanded fractionation facilities, and consistent demand from international clients in chocolate, confectionery and cosmetic sectors.
- Value-added dominance: 70%–75% of sales now come from value-added products including cocoa butter equivalent (CBE), stearin and other specialty fats, reflecting the company's strategic shift toward higher-margin offerings.
- Plant utilization: Combined plant utilization reached 80%–85% for H1 on the existing 40,000-ton capacity, up from ~63% last year, with management expecting ~85% for the full year.
- Volume growth: Management expects approximately 25%–30% volume growth from the prior year, supported by capacity expansion and strong demand.
- Client concentration: Top 10 customers contribute approximately 40% of revenue, though management did not disclose individual client contributions.
Ashish Saraf: "Based on the strong performance and business momentum, the company has revised its annual guidance for FY '26 upwards from INR 1,050 crores to INR 1,150 crores plus reflecting our confidence in the demand outlook and operational scalability."
Margins & Profitability
- Margin profile: EBITDA margin of 27.2% and PAT margin of 17.2% reflect focus on product mix optimization, improved capacity utilization and disciplined cost control.
- Margin drivers: Margins are driven more by volume, production efficiency and backward integration (raw material procurement cost) rather than CBE price fluctuations, giving some insulation from commodity swings.
- Sustainability stance: Management expressed confidence in sustaining healthy margins going forward but did not give a direct yes/no on whether margins can improve further from current levels with operating leverage.
- Return ratios: ROCE stood at 49.9% and ROE at 36.9%, with a comfortable debt-to-equity ratio of 0.57:1.
- Working capital improvement: Working capital reduced to 97 days, with management targeting approximately 75 days within the next two years and seeing further room for improvement.
- Cash generation: Strong operating cash flow of ₹189.07 crores in H1 supports the balance sheet strength.
Capacity Expansion & CAPEX
- Immediate expansion: Fractionation capacity will increase from 40,000 to 52,000 metric tons annually through a scheduled plant maintenance and upgradation shutdown in Q3 FY26 (December onwards); the expanded capacity may be live from Q4.
- Shutdown impact: Management stated the plant shutdown will have no impact on annual revenue guidance and will help achieve higher productivity and better throughput in coming quarters.
- Total CAPEX plan: A ~₹450 crore CAPEX project is expected to come on stream in the next two years, covering both the 52,000-ton expansion and additional greenfield capacity on land acquired adjacent to the existing Birkoni facility.
- Funding structure: Management is evaluating options including internal accruals, debt and equity; advanced discussions are ongoing and the structure will be finalized shortly.
- Greenfield timeline: Construction of the additional greenfield facility will take 9–16 months depending on the process, though no specific completion date was committed.
- Revenue potential: At 100% utilization on the full 52,000-ton capacity, management indicated a ballpark revenue potential of ₹1,800–₹2,000 crores, while stressing this is not formal guidance.
- CAPEX breakup declined: Management declined to provide a breakup of the ₹450 crore CAPEX between backward and forward integration, citing the need for certain approvals before disclosing project-wise figures.
CBE Market & Pricing Dynamics
- Price stability: CBE prices have remained in the \$5,500–\$6,000 range even when cocoa butter traded at \$25,000–\$30,000; management does not see price drift in CBE, stearin or other specialty fats and butters.
- Contract structure: Contracts are typically for 9–12 months with volume and pricing fixed once finalized; there is no revision based on cocoa butter spread narrowing, insulating revenue from short-term commodity volatility.
- Demand decoupled from cost: Demand for CBE is growing fast because it provides structural and functional importance (texture, taste, stability) to chocolate and confectionery manufacturers irrespective of cost; it is also a zero trans fat, healthy fat.
- Global market growth: The global CBE market is growing exponentially, including in India and Brazil, and the company holds a very significant portion of the global specialty fats and butters market.
- Market data gap: Management declined to provide global CBE market share or growth rate data, stating they do not have such data.
Ekta Soni: "When cocoa butter was trading at higher, \$25,000-\$30,000 kind of a dollar, our price was still the same. Now, maybe it is fluctuating as you are saying it is down through your channel checks, but still our prices are around that price only \$5,500-\$6,000 US dollars."
Competitive Position & Moat
- Scarce competition: Very few global players manufacture CBE and specialty fats and butters; barriers include sourcing wastage seeds (Sal, Mango Kernel, Shea Nut), building a sustainable supply chain with tribal collectors, securing product approval from top MNCs, and mastering fractionation technology.
- Market leadership: The company is the largest and leading supplier of Sal and Mango-based fats and butters in the world, with no competitors at this scale in India.
- Entry barriers: Management views the foundation required (seed sourcing network, supply chain, approvals, technology) as a significant entry barrier for any newcomer.
Ekta Soni: "Globally, if you see, there are very few companies who are into manufacturing of cocoa butter equivalents and this kind of specialty fats and butters because what we are producing, these cocoa butter equivalents are from the wastage seeds... this could be the competitive landscape, maybe for anybody to come in and do this. But this what we see, it could be the entry barrier for any newcomer to build the foundation."
Geographic Expansion & Backward Integration
- West Africa push: Subsidiaries established in West Africa to streamline procurement of Shea Nuts; an MoU signed with the government of Burkina Faso for setting up a processing facility focused on extraction and expelling, not fractionation or refining.
- Backward integration logic: Setting up extraction and expelling in Burkina Faso will reduce costs by importing butter instead of seeds, while improving inventory management, working capital cycle and inventory days; fractionation and refinery operations will remain in Raipur, Chhattisgarh.
- Latin America entry: An agreement signed with DEKEL in Brazil to utilize their processing facilities for manufacturing specialty fats for the regional market, described as a market penetration play with huge opportunity.
- Domestic expansion: An MoU signed with the Government of Chhattisgarh for potential investment in a future plant CAPEX project.
- Global footprint: Eight subsidiaries established globally across regions including West Africa, Latin America and Brazil.
- Africa CAPEX details withheld: Management declined to quantify backward integration CAPEX in African countries, saying they will discuss project-wise figures at a later stage.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY26 revenue | Revised upward to ₹1,150 crores plus | FY26 full year |
| Fractionation capacity | Expand from 40,000 to 52,000 metric tons annually | Q3 FY26 shutdown; live from Q4 FY26 |
| Plant shutdown impact | No impact on annual revenue guidance | FY26 |
| Total CAPEX project | ~₹450 crores on stream | Within next 2 years |
| Working capital target | ~75 days | Within next 2 years |
| FY27 guidance | Will reaffirm numbers | March quarter (Q4 FY26) |
| Volume growth | ~25%–30% from prior year | FY26 |
| Capacity utilization | ~85% | FY26 |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Revenue | ₹323.3 cr |
| EBITDA | ₹87.7 cr, margin 27.1% |
| Profit after tax | ₹54.9 cr, margin 17% |
| H1 FY26 revenue | ₹612.9 cr, 86.4% YoY growth |
| H1 FY26 EBITDA | ₹156.6 cr, margin 27.2% |
| H1 FY26 PAT | ₹105.5 cr, margin 17.2% |
| FY26 revenue guidance | ₹1,150 cr plus, revised upward from ₹1,050 cr |
| ROCE | 49.9% as of 30th Sep 2025 |
| ROE | 36.9% as of 30th Sep 2025 |
| Net debt-to-equity ratio | 0.57:1 as of 30th Sep 2025 |
| Net operating cash flow | ₹189.07 cr during H1 FY26 |
| Working capital days | 97 days, reduced from 151 days; target of ~75 days |
| Value-added product contribution | 70%–75% of sales |
| Plant utilization | 80%–85% on 40,000 tons combined capacity for H1 |
| Export contribution | 58% of revenue; domestic 42% |
| CBE price realization | \$5,500–\$6,000 per ton |
| Volume growth expectation | ~25%–30% for FY26 vs FY25 |
| Capacity expansion | 40,000 to 52,000 metric tons annually, commissioning from Q4 FY26 |
| Total CAPEX estimate | ~₹450 cr for projects over and above the 40,000-to-52,000-ton upgradation |
| Top 10 customers revenue share | ~40% |
| US export sales | 2%–3% of revenue |